國家衛生研究院 NHRI:Item 3990099045/15940

NHRI > National Institute of Infectious Diseases and Vaccinology > Min-Shi Lee > Periodical Articles > Item 3990099045/15940

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/15940

Title:	Insect cell-based quadrivalent seasonal influenza virus-like particles vaccine elicits potent immune responses in mice
Authors:	Badruzzaman, ATM;Cheng, YC;Sung, WC;Lee, MS
Contributors:	National Institute of Infectious Diseases and Vaccinology
Abstract:	Influenza viruses can cause highly infectious respiratory diseases, posing noteworthy epidemic and pandemic threats. Vaccination is the most cost-effective intervention to prevent influenza and its complications. However, reliance on embryonic chicken eggs for commercial influenza vaccine production presents potential risks, including reductions in efficacy due to HA gene mutations and supply delays due to scalability challenges. Thus, alternative platforms are needed urgently to replace egg-based methods and efficiently meet the increasing demand for vaccines. In this study, we employed a baculovirus expression vector system to engineer HA, NA, and M1 genes from seasonal influenza strains A/H1N1, A/H3N2, B/Yamagata, and B/Victoria, generating virus-like particle (VLP) vaccine antigens, H1N1-VLP, H3N2-VLP, Yamagata-VLP, and Victoria-VLP. We then assessed their functional and antigenic characteristics, including hemagglutination assay, protein composition, morphology, stability, and immunogenicity. We found that recombinant VLPs displayed functional activity, resembling influenza virions in morphology and size while maintaining structural integrity. Comparative immunogenicity assessments in mice showed that our quadrivalent VLPs were consistent in inducing hemagglutination inhibition and neutralizing antibody titers against homologous viruses compared to both commercial recombinant HA and egg-based vaccines (Vaxigrip). The findings highlight insect cell-based VLP vaccines as promising candidates for quadrivalent seasonal influenza vaccines. Further studies are worth conducting.
Date:	2024-06-17
Relation:	Vaccines. 2024 Jun 17;12(6):Article number 667.
Link to:	http://dx.doi.org/10.3390/vaccines12060667
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2076-393X&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:001256645600001
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85197191587
Appears in Collections:	[Min-Shi Lee] Periodical Articles [Wang-Chou Sung] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB38932396.pdf		4828Kb	Adobe PDF	57	View/Open

Loading...